5Ruetsch O , Viala A, Bardou H, et al. psychotropic drugs in- duced weight gain:a review of the literature conceming epidemi- ologicaldata[ J ]. mechanisms and management Encephale,2005, 31 (4 ptl) :507 -516.
6Toren P, Ratner S, Laor N, et al. Benefit - risk assessment of a- typical antipsychotics in the treatment of schizophrenia and co- morbid disorders inchildren andadolescents [ J ]. Drug Saf, 2004, 27:1135 -1156.
7Goughs, Peveler R. Diabetes and its prevention: pragmaticsolut- ions for people with schizophrenia [ J ]. Br J Psychiatry Suppl, 2004,47:106 - 111.
8Zamaria N. Alteration of polyunsaturated fatty acid status and metabolism in health and disease [ J ]. Reprod Nutr Dev, 2004, 44:273 -282.
9Dickerson FB,Goldberg RW,Brown CH,et al. Diabetes knowl- edge among persons with senious mentalillness and type 2 diabe- tes [ J ]. Psychosomatics ,2005,46:418 - 424.
